{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:46:16Z","timestamp":1789386376637,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd006996","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000}}],"reference-count":18,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006996.pub2","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T19:13:41Z","timestamp":1239822821000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pimozide for tics in Tourette's syndrome"],"prefix":"10.1002","author":[{"given":"Tamara","family":"Pringsheim","sequence":"first","affiliation":[{"name":"University of Calgary; Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics; Alberta Children's Hospital, C4-431 2888 Shaganappi Trail NW Calgary Alberta Canada AB T3B 6A8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[{"name":"Toronto Western Hospital; Movement Disorders Clinic; 399 Bathurst Street Toronto ON Canada M5T 2S8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD006996.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel group study.","volume":"62","author":"Bruggeman","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006996.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","article-title":"Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.","volume":"43","author":"Gilbert","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0004|cit3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(77)91126-6","article-title":"Comparison of Pimozide with Haloperidol in Gilles de la Tourette Syndrome","volume":"1","author":"Ross","year":"1977 January","journal-title":"The Lancet"},{"issue":"5","key":"10.1002\/14651858.CD006996.pub2-BIB0003|cit4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.135.5.585","article-title":"A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's Syndrome","volume":"135","author":"Ross","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0006-3223(95)00596-X","article-title":"Prolactin monitoring of halodperidol and pimozide treatment in children with Tourette's syndrome","volume":"40","author":"Sallee","year":"1996","journal-title":"Biological psychiatry"},{"issue":"1057-1062","key":"10.1002\/14651858.CD006996.pub2-BIB0006|cit6","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006996.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","article-title":"Controlled study of pimozide vs placebo in Tourette's syndrome","volume":"23","author":"Shapiro","year":"1984","journal-title":"Journal of the American Academy of Child Psychiatry"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide, and placebo in the treatment of Gilles de la Tourette's Syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0009|cit9","unstructured":"American Psychiatric Association 307.23 Tourette Disorder, Diagnostic and Statistical Manual of Mental Disorders, Text Revision 2000"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second generation antipsychotics: a systematic review of 1 year studies.","volume":"161","author":"Correll","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006996.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0269881105056543","article-title":"Metabolic side effects of atypical antipsychotics in children: a literature review.","volume":"19","author":"Fedorowicz","year":"2005","journal-title":"Journal of Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD006996.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/sim.4780081202","article-title":"The performance of the two-stage analysis of two-treatment, two-period crossover trials.","volume":"8","author":"Freeman","year":"1989","journal-title":"Stat Med"},{"key":"10.1002\/14651858.CD006996.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2307\/2528104","article-title":"The two-period change over design and its use in cliniccal trials.","volume":"21","author":"Grizzle","year":"1965","journal-title":"Biometrics"},{"issue":"3S","key":"10.1002\/14651858.CD006996.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive services task force","volume":"20","author":"Harris","year":"2001","journal-title":"American Journal of Preventive Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006996.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1651-2227.2005.tb01837.x","article-title":"Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background.","volume":"94","author":"Khalifa","year":"2005","journal-title":"Acta Pediatrica"},{"issue":"4","key":"10.1002\/14651858.CD006996.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician rated scale of tic severity.","volume":"28","author":"Leckman","year":"1989","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006996.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s007870070020","article-title":"Gilles de la Tourette syndrome: Symptomatic treatment based on evidence.","volume":"9","author":"Robertson","year":"2000","journal-title":"European child and adolescent psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD006996.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.psychres.2006.03.017","article-title":"Factor analytic study of the Yale Global Tic Severity Scale","volume":"149","author":"Storch","year":"2007","journal-title":"Psychiatry Research"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006996.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:06:09Z","timestamp":1628546769000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006996.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006996.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}